Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Cash from Financing Activities (2023 - 2025)

SeaStar Medical Holding's Cash from Financing Activities history spans 3 years, with the latest figure at $2.3 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 47.83% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $23.8 million, up 34.62%, while the annual FY2025 figure was $23.8 million, 34.62% up from the prior year.
  • Cash from Financing Activities reached $2.3 million in Q4 2025 per ICUCW's latest filing, down from $11.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $11.3 million in Q3 2025 to a low of -$1.0 million in Q2 2024.
  • Average Cash from Financing Activities over 3 years is $4.3 million, with a median of $4.2 million recorded in 2024.
  • Peak YoY movement for Cash from Financing Activities: crashed 169.73% in 2024, then surged 494.98% in 2025.
  • A 3-year view of Cash from Financing Activities shows it stood at $4.6 million in 2023, then fell by 3.44% to $4.4 million in 2024, then crashed by 47.83% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Cash from Financing Activities are $2.3 million (Q4 2025), $11.3 million (Q3 2025), and $4.0 million (Q2 2025).